Gelteq (GELS) Short term Debt (2023 - 2025)

Gelteq (GELS) recorded quarterly Short term Debt of $2.7 million in Q2 2025, up 96.02% quarter-over-quarter from $1.4 million in Q2 2024, and up 96.02% on a YoY basis from $1.4 million in Q2 2024.

Gelteq (GELS) Short term Debt (2023 - 2025) Analysis & Trends

Gelteq's Short term Debt history runs 3 years deep, the most recent figure standing at $2.7 million for Q2 2025.

  • In Q2 2025, Short term Debt rose 96.02% year-over-year to $2.7 million; the TTM figure through Jun 2025 stood at $2.7 million (up 96.02% YoY), while the FY2025 annual figure was $2.7 million, up 96.02% from the prior year.
  • Short term Debt was $2.7 million for Q2 2025 at Gelteq, up from $1.4 million in the prior quarter.
  • In the past five years, Short term Debt ranged from a high of $2.7 million in Q2 2025 to a low of $3399.3 in Q2 2023.
  • Historically, Short term Debt has averaged $1.4 million across 3 years, with a median of $1.4 million in 2024.
  • The sharpest annual moves came in 2024 and 2025: Short term Debt soared 40305.81% in 2024, then jumped 96.02% in 2025.
  • A 3-year view of Short term Debt shows it stood at $3399.3 in 2023, then jumped by 40305.81% to $1.4 million in 2024, then surged by 96.02% to $2.7 million in 2025.
  • The last three Short term Debt figures came in at $2.7 million (Q2 2025), $1.4 million (Q2 2024), and $3399.3 (Q2 2023), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn
10 Gelteq 10.57 Mn 10.34 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2025 2.69 Mn
Jun 30, 2024 1.37 Mn
Jun 30, 2023 3,399.28